Burning Rock Biotech (BNR) Short Interest Ratio & Short Volume → The only AI company to buy (From Porter & Company) (Ad) Free BNR Stock Alerts $7.77 +0.22 (+2.91%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Burning Rock Biotech Short Interest DataCurrent Short Interest54,700 sharesPrevious Short Interest402,400 sharesChange Vs. Previous Month-86.41%Dollar Volume Sold Short$440,335.00Short Interest Ratio11.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares10,240,000 sharesFloat Size8,490,000 sharesShort Percent of Float0.64%Today's Trading Volume2,347 sharesAverage Trading Volume5,843 sharesToday's Volume Vs. Average40% Short Selling Burning Rock Biotech ? Sign up to receive the latest short interest report for Burning Rock Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNR Short Interest Over TimeBNR Days to Cover Over TimeBNR Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Burning Rock Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202454,700 shares $440,335.00 -86.4%0.6%11.4 $8.05 4/30/2024402,400 shares $303,852.24 +1.1%0.5%7.8 $0.76 4/15/2024397,900 shares $318,320.00 -1.9%0.5%8.2 $0.80 3/31/2024405,400 shares $295,171.74 -1.2%0.5%6.2 $0.73 3/15/2024410,300 shares $279,004.00 +2.7%0.5%5.7 $0.68 2/29/2024399,500 shares $340,493.85 -0.5%0.5%5.5 $0.85 Get the Latest News and Ratings for BNR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Burning Rock Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024401,600 shares $325,296.00 -8.1%0.5%5.4 $0.81 1/31/2024437,000 shares $375,820.00 -25.0%0.5%6 $0.86 1/15/2024582,600 shares $541,818.00 +29.1%0.7%8.2 $0.93 12/31/2023451,300 shares $419,709.00 +2.8%0.5%8.1 $0.93 12/15/2023439,000 shares $329,381.70 -6.9%0.5%8.6 $0.75 11/30/2023471,600 shares $391,428.00 -0.9%0.6%7.9 $0.83 11/15/2023476,000 shares $448,439.60 -7.2%0.6%8.8 $0.94 10/31/2023512,700 shares $489,013.26 -6.7%0.6%9.9 $0.95 10/15/2023549,500 shares $560,490.00 -6.3%0.7%8.5 $1.02 9/30/2023586,700 shares $569,099.00 -6.4%0.7%9.1 $0.97 9/15/2023626,800 shares $626,800.00 +18.2%0.7%9.8 $1.00 8/31/2023530,500 shares $718,827.50 -7.6%0.6%8.9 $1.36 8/15/2023574,100 shares $866,891.00 -5.0%0.7%10.8 $1.51 7/31/2023604,500 shares $1.09 million -0.2%0.7%11.4 $1.80 7/15/2023605,600 shares $1.30 million -2.5%0.7%16.6 $2.14 6/30/2023621,000 shares $1.34 million -2.1%0.7%15.3 $2.15 6/15/2023634,400 shares $1.39 million -4.6%0.8%12.4 $2.19 5/31/2023665,100 shares $1.74 million +9.4%0.8%11.4 $2.61 5/15/2023608,200 shares $1.73 million -17.4%0.7%8.2 $2.85 4/30/2023736,000 shares $2.29 million -7.1%0.9%8.4 $3.11 4/15/2023791,900 shares $2.29 million -5.9%0.9%7.1 $2.89 3/31/2023841,100 shares $2.36 million +4.0%N/A6.5 $2.81 3/15/2023809,100 shares $2.40 million -17.4%N/A5.4 $2.97 2/28/2023979,200 shares $3.19 million -8.5%N/A5.5 $3.26 2/15/20231,070,000 shares $3.22 million -13.0%N/A5.5 $3.01 1/31/20231,230,000 shares $3.58 million -17.5%1.4%5.6 $2.91 1/15/20231,490,000 shares $5.04 million -6.3%1.7%6.6 $3.38 12/30/20221,590,000 shares $3.58 million -2.5%1.8%7 $2.25 12/15/20221,630,000 shares $4.52 million -11.9%1.9%6.2 $2.77 11/30/20221,850,000 shares $4.64 million -1.1%2.1%5.6 $2.51 11/15/20221,870,000 shares $4.26 million No Change2.2%5 $2.28 10/31/20221,870,000 shares $3.85 million -2.1%2.2%4.6 $2.06 10/15/20221,910,000 shares $4.13 million -1.6%2.2%4.5 $2.16 9/30/20221,940,000 shares $4.64 million +2.7%2.3%4.2 $2.39Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… 9/15/20221,890,000 shares $6.24 million +18.9%2.2%3 $3.30 8/31/20221,590,000 shares $6.23 million +34.8%1.8%1.9 $3.92 8/15/20221,180,000 shares $4.65 million +18.3%1.4%1.5 $3.94 7/31/2022997,900 shares $3.18 million +9.7%1.2%1.2 $3.19 7/15/2022909,700 shares $2.90 million +70.9%1.1%1.1 $3.19 6/30/2022532,200 shares $1.55 million +39.2%0.6%0.7 $2.91 6/15/2022382,300 shares $791,361.00 -15.9%0.4%0.6 $2.07 5/31/2022454,600 shares $1.09 million -53.6%0.5%1.2 $2.40 5/15/2022980,500 shares $3.26 million -19.0%1.1%3.2 $3.32 4/30/20221,210,000 shares $6.67 million -4.0%1.4%4.7 $5.51 4/15/20221,260,000 shares $9.11 million -6.0%1.5%4.6 $7.23 3/31/20221,340,000 shares $12.45 million +3.9%1.6%4.8 $9.29 3/15/20221,290,000 shares $8.64 million +4.9%1.5%4.7 $6.70 2/28/20221,230,000 shares $10.37 million +5.1%1.4%4.3 $8.43 2/15/20221,170,000 shares $9.73 million +5.4%1.4%3 $8.32 1/31/20221,110,000 shares $9.99 million +4.7%1.3%2.7 $9.00 1/15/20221,060,000 shares $9.61 million +7.5%1.2%2.7 $9.07 12/31/2021986,000 shares $9.40 million +0.0%1.2%2.4 $9.53 12/15/2021985,700 shares $10.53 million -43.4%1.2%2.4 $10.68 11/30/20211,740,000 shares $26.90 million +4.8%2.0%4.8 $15.46 11/15/20211,660,000 shares $22.83 million -19.8%1.9%5.8 $13.75 10/29/20212,070,000 shares $29.17 million +9.0%2.4%8.6 $14.09 10/15/20211,900,000 shares $27.28 million +8.6%2.2%7.2 $14.36 9/30/20211,750,000 shares $31.29 million +31.6%2.1%7.2 $17.88 9/15/20211,330,000 shares $25.62 million +7.3%1.6%5.4 $19.26 8/31/20211,240,000 shares $23.10 million -0.8%1.5%5.1 $18.63 8/13/20211,250,000 shares $26.74 million -8.8%1.5%3.6 $21.39 7/30/20211,370,000 shares $31.21 million +8.7%1.6%3.6 $22.78 7/15/20211,260,000 shares $34.03 million -10.0%N/A3.6 $27.01 6/30/20211,400,000 shares $41.24 million -5.4%N/A3.8 $29.46 6/15/20211,480,000 shares $41.19 million +42.3%N/A3.8 $27.83 5/28/20211,040,000 shares $28.15 million +5.3%N/A2.6 $27.07 5/14/2021988,100 shares $28.51 million -31.4%1.1%2.8 $28.85 4/30/20211,440,000 shares $43.27 million -9.4%1.7%4.4 $30.05 4/15/20211,590,000 shares $48.50 million +62.5%1.8%4.4 $30.50 3/31/2021978,500 shares $24.73 million +4.6%1.1%2.4 $25.27 3/15/2021935,200 shares $25.33 million +131.7%N/A2.5 $27.09 2/26/2021403,600 shares $14.65 million +8.5%N/A1.2 $36.30 2/12/2021371,900 shares $12.67 million +0.6%0.4%1.2 $34.06 1/29/2021369,700 shares $10.93 million -5.2%0.4%1.4 $29.57 1/15/2021389,800 shares $10.72 million No Change0.5%1.7 $27.50 BNR Short Interest - Frequently Asked Questions What is Burning Rock Biotech's current short interest? Short interest is the volume of Burning Rock Biotech shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 54,700 shares of BNR short. 0.64% of Burning Rock Biotech's shares are currently sold short. Learn More on Burning Rock Biotech's current short interest. What is a good short interest ratio for Burning Rock Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNR shares currently have a short interest ratio of 11.0. Learn More on Burning Rock Biotech's short interest ratio. What is a good short interest percentage for Burning Rock Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.64% of Burning Rock Biotech's floating shares are currently sold short. Is Burning Rock Biotech's short interest increasing or decreasing? Burning Rock Biotech saw a drop in short interest in May. As of May 15th, there was short interest totaling 54,700 shares, a drop of 86.4% from the previous total of 402,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Burning Rock Biotech's float size? Burning Rock Biotech currently has issued a total of 10,240,000 shares. Some of Burning Rock Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Burning Rock Biotech currently has a public float of 8,490,000 shares. How does Burning Rock Biotech's short interest compare to its competitors? 0.64% of Burning Rock Biotech's shares are currently sold short. Here is how the short interest of companies compare to Burning Rock Biotech: Genetron Holdings Limited (0.08%), Sera Prognostics, Inc. (1.37%), Biodesix, Inc. (0.30%), Personalis, Inc. (2.74%), Enzo Biochem, Inc. (1.69%), Exagen Inc. (0.34%), Renalytix Plc (0.58%), Psychemedics Co. (0.20%), DermTech, Inc. (8.94%), BioNexus Gene Lab Corp. (1.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Burning Rock Biotech stock? Short selling BNR is an investing strategy that aims to generate trading profit from Burning Rock Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Burning Rock Biotech? A short squeeze for Burning Rock Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNR, which in turn drives the price of the stock up even further. How often is Burning Rock Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNR, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Genetron Short Interest Data Sera Prognostics Short Interest Data Biodesix Short Interest Data Personalis Short Interest Data Enzo Biochem Short Interest Data Exagen Short Interest Data Renalytix Short Interest Data Psychemedics Short Interest Data DermTech Short Interest Data BioNexus Gene Lab Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNR) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe #1 Crypto for AIWeiss RatingsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.